POWERED BY MOMENTUM MEDIA
Superannuation funds should look to innovation: Peter Beattie
Former Queensland Premier Peter Beattie has urged Australian superannuation funds to consider investing in innovation via appropriate models.
Addressing the Conference of Major Super Funds in Brisbane, Beattie outlined the success enjoyed by the Medical Research Commercialisation Fund (MRCF) and the involvement of two superannuation funds in the underlying model.
He said he believed the MRCF model provided a model that was unique and worth following.
Beattie said this was particularly the case when Australia spent more than $1 billion on research and development, but a fraction of that on commercialisation.
He said he believed Australia should develop a pool of funds for commercialising its research ideas and that superannuation funds should support the establishment of that pool of funds.
AUTHOR
Mike Taylor
Recommended for you
Governor Bullock took a more hawkish stance on Tuesday, raising concerns over Trump’s escalating tariffs, which sent economists in different directions with their predictions.
Equity Trustees has announced the appointment of Jocelyn Furlan to the Superannuation Limited (ETSL) and HTFS Nominees Pty Ltd (HTFS) boards, which have oversight of one of the companies’ fastest growing trustee services.
Following growing criticism of the superannuation industry’s influence on capital markets and its increasing exposure to private assets, as well as regulators’ concerns about potential risks to financial stability, ASFA has released new research pushing back on these narratives.
A US-based infrastructure specialist has welcomed the $93 billion fund as a cornerstone investor.
TOP PERFORMING FUNDS
ACS FIXED INT - AUSTRALIA/GLOBAL BOND
Fund name
3y(%)pa
1
Global X GlobalX FANG+ ETF
33.51 3 y p.a(%)
2
Spire Oaktree Opportunities XI Second Close
32.68 3 y p.a(%)
3
DomaCom Lot 21 Chellaston Road Munno Para West SA 5115 Australia
31.62 3 y p.a(%)
4
Spire Oaktree Opportunities XI First Close USD
31.36 3 y p.a(%)
5
Fidante Credit Suisse Global Private Equity
29.60 3 y p.a(%)
